Supplementation with quercetin alleviates obesity by restoring the gut microbiota dysbiosis induced by HFD in obese mice, thereby increasing IPA levels to activate the AhR/IL-22 pathway, which enhances intestinal barrier integrity and suppresses chronic inflammation (132). Here, IL22 is linked to obesity due to melanocortin 4 receptor deficiency.